You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

elotuzumab

Showing 26 - 42 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Elotuzumab
  • +2 more
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Multiple Myeloma Trial in Worldwide (Selinexor, Elotuzumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +67 more
Jul 26, 2022

Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Denver, Colorado
  • +8 more
May 19, 2022

Multiple Myeloma Trial in Little Rock (drug, procedure, biological)

Withdrawn
  • Multiple Myeloma
  • Elotuzumab
  • +4 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jul 8, 2020

Multiple Myeloma Trial in Germany (elotuzumab, Lenalidomide, Bortezomib)

Completed
  • Multiple Myeloma
  • elotuzumab
  • +3 more
  • Aschaffenburg, Germany
  • +67 more
Sep 9, 2021

Multiple Myeloma Trial in Paris (Elotuzumab)

Withdrawn
  • Multiple Myeloma
  • Elotuzumab
  • Paris, France
    Hématologie et thérapie cellulaire, Hôpital Saint Antoine
Jul 15, 2019

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

Multiple Myeloma Trial in United States (Elotuzumab, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Elotuzumab
  • +2 more
  • Tucson, Arizona
  • +28 more
Jul 8, 2019

Multiple Myeloma Trial in Boston (Dexamethasone, Pomalidomide, Elotuzumab)

Withdrawn
  • Multiple Myeloma
  • Boston, Massachusetts
  • +2 more
Aug 10, 2018

Multiple Myeloma Trial in Little Rock (Elotuzumab, Lenalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Elotuzumab
  • +3 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jan 25, 2019

Hematologic Cancer Trial (elotuzumab, lenalidomide, dexamethasone oral)

Completed
Has Results
  • Hematologic Cancer
  • elotuzumab
  • +3 more
  • (no location specified)
Jan 8, 2018

Multiple Myeloma Trial in Spain (Nivolumab, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Badalona, Spain
  • +11 more
May 22, 2018

Multiple Myeloma Trial in Worldwide (Elotuzumab, Bortezomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Elotuzumab
  • +2 more
  • Corona, California
  • +76 more
Apr 20, 2018

Multiple Myeloma Trial in Spain, United States (Elotuzumab, Lirilumab, Urelumab)

Completed
  • Multiple Myeloma
  • Elotuzumab
  • +2 more
  • Little Rock, Arkansas
  • +6 more
Oct 30, 2017

Multiple Myeloma Trial in New York (Elotuzumab, Lenalidomide, autologous PBMC reconstitution)

Completed
  • Multiple Myeloma
  • Elotuzumab
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 15, 2017

Multiple Myeloma Trial (Elotuzumab, Bortezomib, Lenalidomide)

Withdrawn
  • Multiple Myeloma
  • Elotuzumab
  • +3 more
  • (no location specified)
Apr 12, 2017

Multiple Myeloma Trial in New York (Elotuzumab)

No longer available
  • Multiple Myeloma
  • Elotuzumab
  • New York, New York
    Icahn School.of Medicine at Mount Sinai
Sep 2, 2015